D. Torres

Immunization with a DNA vaccine candidate in chronic hepatitis C patients is safe, well tolerated and does not impair immune response induction after anti‐hepatitis B vaccination

E. Ferrer, B. Acevedo, G. Márquez, 2010, The journal of gene medicine.

Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant.

A. Musacchio, Y. Soria, V. Falcón, 2009, Biological research.

A C-terminal truncated hepatitis C virus core protein variant assembles in vitro into virus-like particles in the absence of structured nucleic acids.

V. Falcón, G. Márquez, J. Aguilar, 2005, Biochemical and biophysical research communications.

New alternatives for the development of vaccine preparations : contributions to the knowledge on the interaction of recombinant protein viral antigens with nucleic acids

P. López-Saura, A. Musacchio, Y. Soria, 2008 .

Increased bioavailability of IFN a 2 b modificed by chemical conjugation to a two-branched polyethyleneglycol molecule

P. López-Saura, I. García, C. Peniche, 2016 .